首页> 美国卫生研究院文献>NPJ Primary Care Respiratory Medicine >Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control

【2h】

Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control

机译：布地奈德/福莫特罗维持和缓解治疗在初级保健哮喘管理中的作用：对支气管高反应性和哮喘控制的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:The management of asthma has changed since the introduction of budesonide/formoterol (Symbicort^®) as both maintenance and reliever therapy (SMART). SMART and its effects on bronchial hyperresponsiveness (BHR) have not been studied in primary care.

机译：背景：自从采用布地奈德/福莫特罗（Symbicort ^{®）作为维持和缓解药物（SMART）以来，哮喘的治疗方法已发生变化。在初级保健中尚未研究SMART及其对支气管高反应性（BHR）的影响。}

著录项

期刊名称 NPJ Primary Care Respiratory Medicine
作者
Roland A Riemersma; Dirkje Postma; Thys van der Molen;
展开▼
作者单位

展开▼
年(卷),期 2012(21),1
年度 2012
页码 50–56
总页数 8
原文格式 PDF
正文语种
中图分类呼吸生理学;
关键词
asthma management primary care randomised controlled trial SMART bronchial hyperresponsiveness;

机译：哮喘;管理;初级保健;随机对照试验;SMART;支气管高反应性;

相似文献

外文文献
中文文献
专利

1. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial (vol 394, pg 919, 2019) [J] . Hardy J., Baggott C., Fingleton J. The Lancet . 2020,第10234期

机译：Budesonide-formoterol refiever治疗与维护Budesonide加上特布尔氨酸救济疗法加上患有轻度至中度哮喘的成人（实用）：52周，开放式标签，多方形，优势，随机对照试验（Vol 394，PG 919,2019）
2. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial [J] . Hardy Jo, Baggott Christina, Fingleton James, The Lancet . 2019,第10202期

机译：Budesonide-Formoterol Reliever疗法与维护培养蛋白质加上特布尔胺救济疗法加入患有轻度至中度哮喘（实用）的成人（实用）：52周，开放式标签，多方形，优势，随机对照试验
3. The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy [J] . Roland Buhl, Piotr Kuna, Matthew J Peters, Respiratory Research . 2012,第1期

机译：布地奈德/福莫特罗维持和缓解疗法对高缓解剂使用后严重哮喘加重风险的影响：对两项随机对照研究的探索性分析，与标准疗法进行了比较
4. Prediction of osmotic airway hyperresponsiveness in patients with bronchial asthma using adaptive neuro-fuzzy network [C] . Kolosov Victor P., Bezrukov Nikolay S., Naumov Denis Ye., 2015 International Conference on Biomedical Engineering and Computational Technologies . 2015

机译：自适应神经模糊网络预测支气管哮喘患者的渗透气道高反应性
5. A controlled release formulation of a budesonide prodrug for asthma inhalation therapy. [D] . Waters, Robert Chad. 2015

机译：布地奈德前药的控释制剂，用于哮喘吸入治疗。
6. The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised controlled studies with comparisons to standard therapy [O] . Roland Buhl, Piotr Kuna, Matthew J Peters, 2012

机译：布地奈德/福莫特罗维持和缓解疗法对高缓解剂使用后严重哮喘加重风险的影响：与标准疗法比较的两项随机对照研究的探索性分析
7. Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control [O] . Roland A Riemersma, Dirkje Postma, Thys van der Molen 2011

机译：布地奈德/福莫特罗维持和缓解治疗初级保健哮喘管理：对支气管高反应性和哮喘控制的影响

Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control

摘要

著录项

相似文献

相关主题

期刊订阅